Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +52.24%
#3 Glidr Glidr +36.41%
#4 Walrus Walrus +29.81%
#5 Cysic Cysic +20.00%
#6 The Black Bull The Black Bull +18.44%
#7 Humanity Humanity +15.87%
#8 Fabric Protocol Fabric Protocol +14.98%
#9 Nockchain Nockchain +14.31%
#10 Tutorial Tutorial +13.13%
Coin of the day
EXOD EXOD
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Hisse Senetlerindeki Sıralama #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Hisse Fiyatı
$0.00060315
Son senkronizasyon: 2024-09-27
Piyasa Değeri
$1.65M
Değişim (1 gün)
19.64%
Değişim (1 yıl)
0.00%
Ülke
SE
Ticaret Amniotics AB (publ) (AMNI)

Kategori

Healthcare
Amniotics AB (publ) (AMNI) için kazanç
Dec 2023 itibarıyla kazanç TTM: $-3.09M
Amniotics AB (publ) şirketinin en son finansal raporlarına göre, mevcut kazancı $-3.09M'dir. 2022 yılında şirket $-4.61M kazanç elde etti, bu 2021 yılındaki $-5.92M kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Amniotics AB (publ) için kazanç geçmişi 2018 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-3.09M 0.85%
2023 $-3.06M -33.59%
2022 $-4.61M -22.23%
2021 $-5.92M 57.96%
2020 $-3.75M 235.76%
2019 $-1.12M 45.50%
2018 $-767.77K 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -171,033.57%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -63,310.98%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -97,500.51%
BE